117 related articles for article (PubMed ID: 16803538)
1. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 polymorphism and risk of gynecological malignancy in Japan.
Sugawara T; Nomura E; Sagawa T; Sakuragi N; Fujimoto S
Int J Gynecol Cancer; 2003; 13(6):785-90. PubMed ID: 14675315
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
Chan QK; Khoo US; Ngan HY; Yang CQ; Xue WC; Chan KY; Chiu PM; Ip PP; Cheung AN
Clin Cancer Res; 2005 Apr; 11(8):2981-5. PubMed ID: 15837751
[TBL] [Abstract][Full Text] [Related]
6. [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis].
Dai LP; Wang YP; Wu XB; Wang KJ; Lv QJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1198-202. PubMed ID: 20193595
[TBL] [Abstract][Full Text] [Related]
7. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T
In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011
[TBL] [Abstract][Full Text] [Related]
8. CYP1A1 polymorphism in adolescents with polycystic ovary syndrome.
Akgül S; Derman O; Alikaşifoğlu M; Aktaş D
Int J Gynaecol Obstet; 2011 Jan; 112(1):8-10. PubMed ID: 20965504
[TBL] [Abstract][Full Text] [Related]
9. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1 gene polymorphism and polycystic ovary syndrome.
Esinler I; Aktas D; Otegen U; Alikasifoglu M; Yarali H; Tuncbilek E
Reprod Biomed Online; 2008 Mar; 16(3):356-60. PubMed ID: 18339256
[TBL] [Abstract][Full Text] [Related]
11. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
[TBL] [Abstract][Full Text] [Related]
12. Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.
Ivanova TI; Krikunova LI; Ryabchenko NI; Mkrtchyan LS; Khorokhorina VA; Salnikova LE
Oxid Med Cell Longev; 2015; 2015():593658. PubMed ID: 25741405
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic (giant and/or spindle cell) carcinoma of lung shows a high percentage of variant CYP1A12.
Przygodzki RM; Koss MN; O'Leary TJ
Mol Diagn; 2001 Jun; 6(2):109-15. PubMed ID: 11468695
[TBL] [Abstract][Full Text] [Related]
14. [Association of CYP1A1 Ile462Val polymorphisms with susceptibility to small cell lung cancer].
He B; Lin J; Cao L; Wang H; Rao J; Liu Y; Zhang Z
Wei Sheng Yan Jiu; 2014 May; 43(3):393-6, 418. PubMed ID: 24964616
[TBL] [Abstract][Full Text] [Related]
15. CYP1A1 genetic polymorphisms and risk for esophageal cancer: a case-control study in central China.
Yun YX; Wang YP; Wang P; Cui LH; Wang KJ; Zhang JY; Dai LP
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6507-12. PubMed ID: 24377558
[TBL] [Abstract][Full Text] [Related]
16. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
Xue K; Xu L; Chen S; Ma G; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.
Huang CS; Shen CY; Chang KJ; Hsu SM; Chern HD
Br J Cancer; 1999 Aug; 80(11):1838-43. PubMed ID: 10468307
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer.
Tsuchiya Y; Sato T; Kiyohara C; Yoshida K; Ogoshi K; Nakamura K; Yamamoto M
J Exp Clin Cancer Res; 2002 Mar; 21(1):119-24. PubMed ID: 12071517
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
Basham VM; Pharoah PD; Healey CS; Luben RN; Day NE; Easton DF; Ponder BA; Dunning AM
Carcinogenesis; 2001 Nov; 22(11):1797-800. PubMed ID: 11698341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]